Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
The Neurologist
|
May 12, 2009
10 questions about 4-aminopyridine and the treatment of multiple sclerosis
Christopher T Bever
Neurology
|
January 15, 2003
Patients with clinically isolated syndromes suggestive of MS: does MRI allow earlier diagnosis?
Gavin Giovannoni, Christopher T Bever
Continuum (Minneapolis, Minn.)
|
July 20, 2012
Practice issues in neurology: point of care online resources
Troy Desai, Christopher T Bever
Expert Opinion on Investigational Drugs
|
June 25, 2009
Sustained-release fampridine for multiple sclerosis
Christopher T Bever, Susan Iv Judge
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 9, 2016
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015
Christopher T Bever, Mitchell T Wallin
Pharmacology & Therapeutics
|
February 14, 2006
Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment
Susan I V Judge, Christopher T Bever
Neurology
|
November 1, 2015
Practice improvement requires more than guidelines and quality measures
Bruce Sigsbee, Christopher T Bever, Lyell K Jones
Journal of Telemedicine and Telecare
|
September 2, 2020
Novel use of existing technology: A preliminary study of patient portal use for telerehabilitation
Susan S Conroy, Stacey Harcum, Linda Keldsen, et al.
Archives of Rehabilitation Research and Clinical Translation
|
December 18, 2020
Comparing Home Upper Extremity Activity with Clinical Evaluations of Arm Function in Chronic Stroke
Kavita Bhatnagar, Christopher T Bever, Jing Tian, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 8, 2014
Cell-based delivery of brain-derived neurotrophic factor in experimental allergic encephalomyelitis
Tapas K Makar, Vamshi K C Nimmagadda, David Trisler, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
The Neurologist
|
May 12, 2009
10 questions about 4-aminopyridine and the treatment of multiple sclerosis
Christopher T Bever
Neurology
|
January 15, 2003
Patients with clinically isolated syndromes suggestive of MS: does MRI allow earlier diagnosis?
Gavin Giovannoni, Christopher T Bever
Continuum (Minneapolis, Minn.)
|
July 20, 2012
Practice issues in neurology: point of care online resources
Troy Desai, Christopher T Bever
Expert Opinion on Investigational Drugs
|
June 25, 2009
Sustained-release fampridine for multiple sclerosis
Christopher T Bever, Susan Iv Judge
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 9, 2016
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015
Christopher T Bever, Mitchell T Wallin
Pharmacology & Therapeutics
|
February 14, 2006
Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment
Susan I V Judge, Christopher T Bever
Neurology
|
November 1, 2015
Practice improvement requires more than guidelines and quality measures
Bruce Sigsbee, Christopher T Bever, Lyell K Jones
Journal of Telemedicine and Telecare
|
September 2, 2020
Novel use of existing technology: A preliminary study of patient portal use for telerehabilitation
Susan S Conroy, Stacey Harcum, Linda Keldsen, et al.
Archives of Rehabilitation Research and Clinical Translation
|
December 18, 2020
Comparing Home Upper Extremity Activity with Clinical Evaluations of Arm Function in Chronic Stroke
Kavita Bhatnagar, Christopher T Bever, Jing Tian, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 8, 2014
Cell-based delivery of brain-derived neurotrophic factor in experimental allergic encephalomyelitis
Tapas K Makar, Vamshi K C Nimmagadda, David Trisler, et al.
Page
of 6